FierceBiotech· @FierceBiotech · X·· 9 天前精选AI 评分75
AI 导读
Telix 达成协议，以 16.5 亿美元预付款收购 ITM Isotope Technologies Munich，获得一条研发管线及放射性药物供应网络。该管线中包括一款与诺华 Lutathera 形成竞争的产品。相关链接：https://www.fiercebiotech.com/biotech/analysts-extremely-bullish-telix-beams-novartis-territory-165b-itm-acquisition
推荐理由
交易金额与标的管线构成核心信息，读者可据此了解放射性药物领域的并购动向。
正文
Telix has struck a deal to buy ITM Isotope Technologies Munich for $1.65 billion upfront, securing an R&D pipeline led by a rival to Novartis’ Lutathera and a radiopharmaceutical supply network. https://www.fiercebiotech.com/biotech/analysts-extremely-bullish-telix-beams-novartis-territory-165b-itm-acquisition
来源：FierceBiotech · x.com